Unknown

Dataset Information

0

4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-?B cascade.


ABSTRACT: The NF-?B signaling pathway is a validated oncological target. Here, we applied scaffold hopping to IMD-0354, a presumed IKK? inhibitor, and identified 4-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide (4) as a nM-inhibitor of the NF-?B pathway. However, both 4 and IMD-0354, being potent inhibitors of the canonical NF-?B pathway, were found to be inactive in human IKK? enzyme assays.

SUBMITTER: Pippione AC 

PROVIDER: S-EPMC6084005 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

4-Hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.

Pippione Agnese C AC   Federico Antonella A   Ducime Alex A   Sainas Stefano S   Boschi Donatella D   Barge Alessandro A   Lupino Elisa E   Piccinini Marco M   Kubbutat Michael M   Contreras Jean-Marie JM   Morice Christophe C   Al-Karadaghi Salam S   Lolli Marco L ML  

MedChemComm 20170825 9


The NF-κB signaling pathway is a validated oncological target. Here, we applied scaffold hopping to IMD-0354, a presumed IKKβ inhibitor, and identified 4-hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide (<b>4</b>) as a nM-inhibitor of the NF-κB pathway. However, both <b>4</b> and IMD-0354, being potent inhibitors of the canonical NF-κB pathway, were found to be inactive in human IKKβ enzyme assays. ...[more]

Similar Datasets

| S-EPMC2980148 | biostudies-literature
| S-EPMC4471478 | biostudies-literature
| S-EPMC3998476 | biostudies-literature
| S-EPMC8398255 | biostudies-literature
| S-EPMC3011692 | biostudies-literature
| S-EPMC2971256 | biostudies-other
| S-EPMC2915299 | biostudies-literature
| S-EPMC5106766 | biostudies-literature
| S-EPMC2961300 | biostudies-literature
| S-EPMC2961496 | biostudies-literature